000 | 01875 a2200517 4500 | ||
---|---|---|---|
005 | 20250516001657.0 | ||
264 | 0 | _c20101123 | |
008 | 201011s 0 0 eng d | ||
022 | _a1471-2210 | ||
024 | 7 |
_a10.1186/1471-2210-10-11 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Che-Chuan | |
245 | 0 | 0 |
_aBeneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia. _h[electronic resource] |
260 |
_bBMC pharmacology _cSep 2010 |
||
300 |
_a11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAgmatine _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aAquaporin 4 _xmetabolism |
650 | 0 | 4 |
_aAstrocytes _xdrug effects |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aBrain Edema _xprevention & control |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
650 | 0 | 4 |
_aGliosis _xprevention & control |
650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xdrug therapy |
650 | 0 | 4 |
_aIschemic Attack, Transient _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMovement Disorders _xdrug therapy |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReperfusion Injury _xprevention & control |
650 | 0 | 4 |
_aSensation Disorders _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aChio, Chung-Ching | |
700 | 1 | _aChang, Ching-Hong | |
700 | 1 | _aKuo, Jinn-Rung | |
700 | 1 | _aChang, Ching-Ping | |
773 | 0 |
_tBMC pharmacology _gvol. 10 _gp. 11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2210-10-11 _zAvailable from publisher's website |
999 |
_c20148778 _d20148778 |